EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Activation of Shh/Smo is sufficient to maintain oligodendrocyte precursor cells in an undifferentiated state and is not necessary for myelin formation and (re)myelination

Sonia Nocera iD, Miguel A Marchena iD, Beatriz Fernández-Gómez iD, Paula Gómez-Martín iD, Estefanía Sánchez-Jiménez iD, Alba Macías-Castellano iD, Yolanda Laó iD, Christian Cordano iD, Óscar Gómez-Torres iD, Rafael Luján iD, Fernando de Castro iD

Glia · 2024

DOI: 10.1002/glia.24540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Sonia Nocera und 10 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain. Hauptthemen laut MEDLINE: Hedgehog Proteins, Oligodendrocyte Precursor Cells, Smoothened Receptor, Myelin Sheath. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Ramón Areces, Ministerio de Ciencia e Innovación, Comunidad de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myelination is the terminal step in a complex and precisely timed program that orchestrates the proliferation, migration and differentiation of oligodendroglial cells. It is thought that Sonic Hedgehog (Shh) acting on Smoothened (Smo) participates in regulating this process, but that these effects are highly context dependent. Here, we investigate oligodendroglial development and remyelination from three specific transgenic lines: NG2‐Cre ERT2 (control), Smo fl/fl /NG2‐Cre ERT2 (loss of function), and SmoM2/NG2‐Cre ERT2 (gain of function), as well as pharmacological manipulation that enhance or inhibit the Smo pathway (Smoothened Agonist (SAG) or cyclopamine treatment, respectively). To explore the effects of Shh/Smo on differentiation and myelination in vivo, we developed a highly quantifiable model by transplanting oligodendrocyte precursor cells (OPCs) in the retina. We find that myelination is greatly enhanced upon cyclopamine treatment and hypothesize that Shh/Smo could promote OPC proliferation to subsequently inhibit differentiation. Consistent with this hypothesis, we find that the genetic activation of Smo significantly increased numbers of OPCs and decreased oligodendrocyte differentiation when we examined the corpus callosum during development and after cuprizone demyelination and remyelination. However, upon loss of function with the conditional ablation of Smo, myelination in the same scenarios are unchanged. Taken together, our present findings suggest that the Shh pathway is sufficient to maintain OPCs in an undifferentiated state, but is not necessary for myelination and remyelination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hedgehog ProteinsOligodendrocyte Precursor CellsSmoothened ReceptorMyelin SheathMice, TransgenicCell DifferentiationAnimalsVeratrum AlkaloidsMiceRemyelinationOligodendrogliaMice, Inbred C57BLSignal Transduction

Stichwörter der Autor:innen

developmentintravitreal injectionmultiple sclerosismyelinationoligodendrocyte precursor cellsmoothenedsonic hedgehog

Substanzen

Hedgehog ProteinsSmoothened ReceptorSmo protein, mouseShh protein, mouseVeratrum Alkaloidscyclopamine

Autor:innen und Institutionen

  • Grupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
  • Facultad HM de Ciencias de la Salud de la UCJC, Universidad Camilo José Cela, Madrid, Spain.
  • NeuroLab, Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.
  • Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, California, USA.
  • Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health. University of Genoa, Italy.
  • Department of Neuroscience, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

ORCID-Profile: Sonia Nocera, Miguel A Marchena, Beatriz Fernández-Gómez, Paula Gómez-Martín, Estefanía Sánchez-Jiménez, Alba Macías-Castellano, Yolanda Laó, Christian Cordano, Óscar Gómez-Torres, Rafael Luján, Fernando de Castro

Förderung

  • Fundación Ramón Areces
  • Ministerio de Ciencia e Innovación
  • Comunidad de Madrid
  • Universidad de Castilla-La Mancha
  • Fundación Inocente, Inocente
  • Consejo Superior de Investigaciones Científicas

Zitieren

APA

Nocera, S., Marchena, M. A., Fernández-Gómez, B., Gómez-Martín, P., Sánchez-Jiménez, E., Macías-Castellano, A., Laó, Y., Cordano, C., Gómez-Torres, Ó., Luján, R., & de Castro, F. (2024). Activation of Shh/Smo is sufficient to maintain oligodendrocyte precursor cells in an undifferentiated state and is not necessary for myelin formation and (re)myelination. Glia. https://doi.org/10.1002/glia.24540

Vancouver

Nocera S, Marchena MA, Fernández-Gómez B, Gómez-Martín P, Sánchez-Jiménez E, Macías-Castellano A, et al. Activation of Shh/Smo is sufficient to maintain oligodendrocyte precursor cells in an undifferentiated state and is not necessary for myelin formation and (re)myelination. Glia. 2024. doi:10.1002/glia.24540

BibTeX
@article{Nocera2024,
  author = {Nocera, Sonia and Marchena, Miguel A and Fernández-Gómez, Beatriz and Gómez-Martín, Paula and Sánchez-Jiménez, Estefanía and Macías-Castellano, Alba and Laó, Yolanda and Cordano, Christian and Gómez-Torres, Óscar and Luján, Rafael and de Castro, Fernando},
  title = {Activation of Shh/Smo is sufficient to maintain oligodendrocyte precursor cells in an undifferentiated state and is not necessary for myelin formation and (re)myelination},
  journal = {Glia},
  year = {2024},
  doi = {10.1002/glia.24540}
}
Kostenlos starten →